Delivery Order SPE2DB22D2005-SPE2DB24FJQP0
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of 4,565,423,496 units of Vyvanse 40 mg capsules. The contract has a ceiling value of $1,972.15 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 13, 2024. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The $4,560.88 firm-fixed-price contract is for the delivery of 4,565,752,664 units of the pharmaceutical drug Vyvanse 40mg capsules to support federal healthcare requirements. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen, as a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $29,271.23 firm-fixed-price delivery order is for the supply of 4,565,174,926 units of the prescription drug Vyvanse (lisdexamfetamine dimesylate) 40 mg capsules. This contract has no set-aside designation and will be performed in Conshohocken, Pennsylvania, with a completion date of July 18, 2024. Amerisourcebergen, a major...
This federal contract award, with the ID SPE2DX15D3008|SPE2DX24F12DU, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,763.94 firm-fixed-price delivery order is for the supply of 4,565,038,024 units of the prescription drug Vyvanse 40 mg capsules. This contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,243,953 units of the prescription medication Vyvanse (20 mg capsules) over a two-year period ending on July 25, 2024. The $2,197.44 firm fixed price contract is a delivery order that is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, will supply these medications to...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FV32T, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,308.00 firm fixed-price delivery order is for the supply of 4,565,230,483 units of the medication Vyvanse 40 mg capsules. The contract has a period of performance through July 24, 2024 and does not have a set-aside designation, indicating open competition....
The Defense Logistics Agency (DLA) has awarded a $9,524.76 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,565,333,941 units of the prescription drug Vyvanse 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,084.86 and is for the delivery of 4,566,526,084 units of the drug Vyvanse 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. This appears to be a task order under a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,728,779 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $2,675.40 and a period of performance through December 17, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,761.14 firm fixed-price delivery order is for the supply of 100 units of Vyvanse 40 mg capsules. The contract has a completion date of September 6, 2024, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...